In many reports to date, the action of agonists on TRPV1 has been found to inhibit cell migration; therefore, capsaicin and related TRPV1 agonists are considered to have the potential to inhibit cancer progression, leading to anticipation that they may be effective as antitumor drugs. This evidence concerns the gene TRPV1 and cancer.